Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1967 1
1968 1
1969 2
1970 1
1973 1
1977 2
1978 3
1979 2
1980 1
1981 1
1982 4
1983 5
1984 6
1985 8
1986 7
1987 7
1988 10
1989 4
1990 7
1991 6
1992 6
1993 4
1994 5
1995 9
1996 12
1997 10
1998 11
1999 14
2000 16
2001 16
2002 19
2003 20
2004 22
2005 8
2006 7
2007 11
2008 8
2009 7
2010 13
2011 21
2012 21
2013 13
2014 11
2015 25
2016 21
2017 23
2018 28
2019 26
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

461 results
Results by year
Filters applied: . Clear all
Page 1
A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Oki E, Murata A, Yoshida K, Maeda K, Ikejiri K, Munemoto Y, Sasaki K, Matsuda C, Kotake M, Suenaga T, Matsuda H, Emi Y, Kakeji Y, Baba H, Hamada C, Saji S, Maehara Y. Oki E, et al. Among authors: Saji S. Ann Oncol. 2016 Jul;27(7):1266-72. doi: 10.1093/annonc/mdw162. Epub 2016 Apr 7. Ann Oncol. 2016. PMID: 27056996 Free PMC article. Clinical Trial.
Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical Trial.
Yoshino T, Yamanaka T, Oki E, Kotaka M, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Takeuchi S, Bando H, Taniguchi H, Gamoh M, Shiozawa M, Mizushima T, Saji S, Maehara Y, Ohtsu A, Mori M. Yoshino T, et al. Among authors: Saji S. JAMA Oncol. 2019 Sep 12;5(11):1574-81. doi: 10.1001/jamaoncol.2019.2572. Online ahead of print. JAMA Oncol. 2019. PMID: 31513248 Free PMC article.
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.
Tomita N, Kunieda K, Maeda A, Hamada C, Yamanaka T, Sato T, Yoshida K, Boku N, Nezu R, Yamaguchi S, Mishima H, Sadahiro S, Muro K, Ishiguro M, Sakamoto J, Saji S, Maehara Y. Tomita N, et al. Among authors: Saji S. Br J Cancer. 2019 Apr;120(7):689-696. doi: 10.1038/s41416-019-0410-0. Epub 2019 Mar 5. Br J Cancer. 2019. PMID: 30833647 Free PMC article. Clinical Trial.
Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
Yoshino S, Nishikawa K, Morita S, Takahashi T, Sakata K, Nagao J, Nemoto H, Murakami N, Matsuda T, Hasegawa H, Shimizu R, Yoshikawa T, Osanai H, Imano M, Naitoh H, Tanaka A, Tajiri T, Gochi A, Suzuki M, Sakamoto J, Saji S, Oka M. Yoshino S, et al. Among authors: Saji S. Eur J Cancer. 2016 Sep;65:164-71. doi: 10.1016/j.ejca.2016.06.012. Epub 2016 Aug 5. Eur J Cancer. 2016. PMID: 27501505 Free article. Clinical Trial.
Alda-1 attenuates hyperoxia-induced mitochondrial dysfunction in lung vascular endothelial cells.
Patil SS, Hernández-Cuervo H, Fukumoto J, Narala VR, Saji S, Borra M, Alleyn M, Lin M, Soundararajan R, Lockey R, Kolliputi N, Galam L. Patil SS, et al. Among authors: Saji S. Aging (Albany NY). 2019 Jun 17;11(12):3909-3918. doi: 10.18632/aging.102012. Aging (Albany NY). 2019. PMID: 31209184 Free PMC article.
Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication.
Ueno T, Saji S, Masuda N, Iwata H, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Sasano H, Toi M. Ueno T, et al. Among authors: Saji S. ESMO Open. 2019 Feb 27;4(1):e000476. doi: 10.1136/esmoopen-2018-000476. eCollection 2019. ESMO Open. 2019. PMID: 30962956 Free PMC article.
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study.
Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S. Yamamoto Y, et al. Among authors: Saji S. Jpn J Clin Oncol. 2018 Sep 1;48(9):855-859. doi: 10.1093/jjco/hyy097. Jpn J Clin Oncol. 2018. PMID: 30020510 Clinical Trial.
461 results
Jump to page
Feedback